Nel ASA: Key information relating to potential subsequent offering to be carried out by Nel ASA Read more about Nel ASA: Key information relating to potential subsequent offering to be carried out by Nel ASA
Archer Limited: Mandatory notification of trade Read more about Archer Limited: Mandatory notification of trade
Archer Limited: Key information related to the potential subsequent offering Read more about Archer Limited: Key information related to the potential subsequent offering
XXL ASA - Commencement of subscription period for subsequent offering Read more about XXL ASA - Commencement of subscription period for subsequent offering
ING completes share repurchase for employee compensation Read more about ING completes share repurchase for employee compensation
GenSight Biologics Provides Update on LUMEVOQ® Manufacturing and Commercialization Timelines Read more about GenSight Biologics Provides Update on LUMEVOQ® Manufacturing and Commercialization Timelines
The EIB and GeNeuro Sign a EUR 25 Million Credit Line Backed by InvestEU to Support Clinical Developments Against Long-COVID Read more about The EIB and GeNeuro Sign a EUR 25 Million Credit Line Backed by InvestEU to Support Clinical Developments Against Long-COVID
Poxel Announces Publication of Positive Phase 2 Results from Phase 2 NASH Trial (DESTINY-1) for PXL065 in Journal of Hepatology Read more about Poxel Announces Publication of Positive Phase 2 Results from Phase 2 NASH Trial (DESTINY-1) for PXL065 in Journal of Hepatology